Literature DB >> 16197794

Daily high doses of fluoxetine for weight loss and improvement in lifestyle before bariatric surgery.

Jacqueline G Dolfing1, Bruce H R Wolffenbuttel, Nienke M ten Hoor-Aukema, Dave H Schweitzer.   

Abstract

BACKGROUND: The number of gastric restrictive bariatric operations is increasing each year, but about one-fifth of patients will become disappointed due to unsatisfactory weight reduction or annoying complications. We questioned whether weight reduction by taking high doses of fluoxetine improves lifestyle before surgery.
METHODS: 84 severely obese subjects were referred by one bariatric surgeon for medical weight reduction and dietary counseling, before bariatric surgery. Subjects were voluntarily treated with fluoxetine, 60 mg per day, and followed-up at 1, 3, 6 and 12 months. Surgery was scheduled between 6 to 12 months after subjects started to take fluoxetine. Endpoints of this study were body weight reductions, the number of individuals who decided for themselves to postpone surgery for at least 6 months, and side-effects of fluoxetine therapy.
RESULTS: 84 severely obese subjects consisting of 28 men (group 1) and 41 women (group 2) consented to take fluoxetine for its anorectic effects, whereas 12 men and 3 women who did not want to take fluoxetine served as the control group (group 3). Weight in these 3 groups at baseline was 149+/-26, 124+/-17, and 132+/-23 (controls) (P<0.05) with BMI 46+/-3, 44+/-3, and 45+/-2 (controls) kg/m(2) (NS). Maximum weight reduction before surgery in male and female fluoxetine users occurred at 3 and 6 months, respectively. At 6 months, men had achieved a weight reduction (kg) of -8.3 (95% CI: -9.3 to -5.9), women of -13.3 (95% CI: -16.3 to -8.8), sex difference P<0.001, and controls of -1.6 (95% CI: -3.8 to -2.5) kg, group difference P<0.0001. Only 2 men stopped fluoxetine because of annoying sexual side-effects. At 6 months, 25 fluoxetine users (29.7%) and none of the controls consented to postpone the time of surgery for at least another 6 months.
CONCLUSION: Fluoxetine is effective to reduce weight in severely obese men and women who originally had requested to undergo bariatric surgery. One-third of subjects who consented to take fluoxetine as an anorectic drug agreed to delay surgery for at least 6 months later than scheduled.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16197794     DOI: 10.1381/0960892055002301

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  3 in total

Review 1.  Adequate nutrition followed by revisional bariatric surgery to optimize homeostatic eating control.

Authors:  Dave H Schweitzer
Journal:  Obes Surg       Date:  2008-01-05       Impact factor: 4.129

Review 2.  Therapeutic options for binge eating disorder.

Authors:  Carla E Ramacciotti; Elisabetta Coli; Donatella Marazziti; Cristina Segura-García; Francesca Brambilla; Armando Piccinni; Liliana Dell'osso
Journal:  Eat Weight Disord       Date:  2013-04-09       Impact factor: 4.652

3.  Preoperative lifestyle intervention in bariatric surgery: initial results from a randomized, controlled trial.

Authors:  M A Kalarchian; M D Marcus; A P Courcoulas; Y Cheng; M D Levine
Journal:  Obesity (Silver Spring)       Date:  2013-02       Impact factor: 5.002

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.